共 189 条
[1]
Ray KK(2020)EU wide cross sectional observational study of lipid modifying therapy use in secondary and primary care: the DA VINCI study Eur J Prev Cardiol 28 1279-89
[2]
Molemans B(2020)Proportion of high-risk/very high-risk patients in Europe with low-density lipoprotein cholesterol at target according to European guidelines: a systematic review Adv Ther 37 1724-1736
[3]
Schoonen WM(2018)Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: insights from Italian general practice Atherosclerosis 271 120-127
[4]
Giovas P(2021)Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes Cardiovasc Diabetol 20 144-2118
[5]
Bray S(2020)Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016 JAMA Netw Open 3 e2025505-8
[6]
Kiru G(2020)LDL-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction—nationwide cohort study, 2013–2017 Eur Heart J Qual Care Clin Outcomes 13 2111-72
[7]
Bruckert E(2019)Adherence to statin therapy and attainment of LDL cholesterol goal among patients with type 2 diabetes and dyslipidemia Patient Prefer Adherence 19 5-41
[8]
Parhofer KG(2020)Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study Lipids Health Dis 6 1060-841
[9]
Gonzalez-Juanatey JR(2021)Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US JAMA Cardiol 19 190-e112
[10]
Nordestgaard B(2020)Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics Cardiovasc Diabetol 38 2459-1033